{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T11:06:51Z","timestamp":1767006411101,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["175034"],"award-info":[{"award-number":["175034"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.mycmed.2012.06.002","type":"journal-article","created":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T09:16:15Z","timestamp":1344590175000},"page":"243-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia"],"prefix":"10.1016","volume":"22","author":[{"given":"A.","family":"Trpkovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pekmezovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bara\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Crn\u010devi\u0107 Radovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Arsi\u0107 Arsenijevi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2012.06.002_bib0005","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/jac\/46.6.997","article-title":"Comparison of the E-test\u00ae and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents","volume":"46","author":"Aller","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.00705-08","article-title":"Established and emerging indications antifungal therapeutic drug monitoring","volume":"53","author":"Andes","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0015","first-page":"90","article-title":"Isolates of Cryptococcus neoformans serotype A or D from cerebrospinal fluid resistant to 5-fluorocytosine","volume":"7","author":"Arsic","year":"1995","journal-title":"J Chemother"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0110","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/QAD.0b013e328352d1d8","article-title":"Decreasing incidence of cryptococcal meningitis in West Africa in the era of highly active antiretroviral therapy","volume":"26","author":"Bamba","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jac\/37.2.265","article-title":"Antifungal susceptibility testing using the E-test\u00ae: comparison with broth macrodilution technique","volume":"37","author":"Chen","year":"1996","journal-title":"J Antimicrob Chemother"},{"year":"2008","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard M27-A3","author":"Clinical Laboratory Standards Institute","key":"10.1016\/j.mycmed.2012.06.002_bib0030"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0035","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1128\/AAC.01520-05","article-title":"Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis","volume":"50","author":"Dannaoui","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1517\/14656566.2012.658773","article-title":"Update on the epidemiology and management of cryptococcal meningitis","volume":"13","author":"Desalermos","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0045","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1099\/jmm.0.46789-0","article-title":"Comparative analysis of E-test\u00ae and broth microdilution method (AFST-EUCAST) for trends in antifungal drug susceptibility testing of Brazilian Cryptococcus neoformans isolates","volume":"55","author":"Dias","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0050","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1086\/514669","article-title":"Flucytosine monotherapy for cryptococcosis","volume":"27","author":"Hospenthal","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0055","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1128\/JCM.36.10.2817-2822.1998","article-title":"Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test\u00ae and National Committee for Clinical Laboratory Standards M27-A methodologies","volume":"36","author":"Lozano-Chin","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0213-005X(10)70007-0","article-title":"Microbiological aspects of the cryptococcosis in the post-HAART era","volume":"28","author":"Mazuelos","year":"2010","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.mycmed.2012.06.002_bib0065","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/jac\/dki393","article-title":"Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans","volume":"56","author":"Perkins","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0070","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1128\/JCM.36.9.2586-2589.1998","article-title":"Evaluation of the E-test\u00ae method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media","volume":"36","author":"Pfaller","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0075","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1128\/JCM.43.8.3807-3810.2005","article-title":"In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans and Aspergillus species to itraconazole: global survey of 9359 isolates tested by Clinical and Laboratory Standards Institute broth microdilution methods","volume":"43","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0080","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/JCM.43.5.2163-2167.2005","article-title":"Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)","volume":"43","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0085","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/515110","article-title":"A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis","volume":"28","author":"Saag","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0090","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/dkh361","article-title":"Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002","volume":"54","author":"Sar","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0095","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/BF01708563","article-title":"Antifungal susceptibility testing of yeast isolates from blood cultures by microbroth dilution and the E-test\u00ae","volume":"16","author":"Simor","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0100","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1439-0507.2006.01242.x","article-title":"In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs","volume":"49","author":"Tay","year":"2006","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2012.06.002_bib0105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1179\/joc.2003.15.2.124","article-title":"Flucytosine and cryptococcosis: which in vitro test is the best predictor of outcome?","volume":"15","author":"Viviani","year":"2003","journal-title":"J Chemother"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523312000674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523312000674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:15:15Z","timestamp":1761110115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523312000674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1156523312000674"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2012.06.002","relation":{},"ISSN":["1156-5233"],"issn-type":[{"type":"print","value":"1156-5233"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2012.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}